VEGFA and ovarian cancer: The inhibition of VEGF-A does not revert these processes, suggesting that another pro-angiogenic factors secreted by surrounding ovarian cancer cells or their microenvironment could be involved in the angiogenic activation of peritoneal ECs during metastasis (18, 19).